(212) 292-4573 tmcinnis@mcinnis-law.com

FCA Successor Liability

Can I still pursue a False Claims Act Qui Tam action if the intended corporate target has been sold to, or merged with, another company? Under FCA Successor Liability law that depends on two things: (1) where you are filing your False Claims Act Qui Tam lawsuit; and (2) what are the terms of sale or merger and the economic realities of the transaction.

There are essentially two competing legal positions on this issue. One is known as the “traditional rule”; the other has been called the “substantial continuity rule.” The traditional rule is more difficult for whistleblowers to satisfy. Under traditional common law rule of successor liability, a corporation that acquires the assets of another corporation does not take the liabilities of the corporation from which the assets are acquired unless one of four exceptions applies: (1) the successor expressly or impliedly agrees to assume the liabilities of the predecessor; (2) the transaction may be considered a de facto merger; (3) the successor may be considered a mere continuation of the predecessor; or (4) the transaction is fraudulent. With regard to the third exception, a corporation is not to be considered the mere continuation of a predecessor unless, after the transfer of assets, only one corporation remains, and there is an identity of stock, stockholders, and directors between the two corporations.

The substantial continuity rule is easier for a whistleblower to establish. Under it one needs to prove only that: (1) that the new company had notice of the whistleblower’s claim before the sale or merger transaction; and (2) the business operations of both the old and new companies are essentially the same, for example the employees of the new company are doing the same jobs in the same working conditions under the same supervisors and the new company has the same production process, produces the same products or provides the same services, and basically has the same body of customers or clients. The notice requirement can be met in some cases simply by showing continuity in ownership and/or senior management.

Federal courts in different parts of the United States have applied one or the other of these competing rules to FCA cases. Recently, the US District Court in the Eastern District of Virginia applied the more stringent traditional rule in US ex rel. Bunk v. Birkart Globistics, No. l:02-cv-1168(AJT/TRJ) (Sept. 9, 2014).  In contrast, the US District Court in the District of D.C. applied the more lax substantial continuity test in United States ex rel Fisher v. Network Software Assocs., Inc., 180 F. Supp. 2d 192 (D.D.C. 2002).

The practical take away from this analysis: have a clear understanding of the legal technicalities of the sale or merger (especially in terms of how the old company’s liabilities are treated), know what the business operations and organizational structures were before and after the transaction, and choose a court that has favorably decided the successor liability question, as well as other legal issues relevant to your case, in the past.

Atty McInnis Introduces US Atty to Whistleblower Lawyers

Atty McInnis Introduces US Atty to Whistleblower Lawyers

qui-tam-lawyer

Relator’s Counsel Timothy J. McInnis introduced US Attorney Richard Hartunian from the Northern District of New York at the Taxpayers Against Fraud Education Fund’s (TAFEF) 14th annual whistleblower False Claims Act (FCA) conference in Washington, D.C.  Approximately 300 whistleblower lawyers from throughout the United States attended the three day conference.  During his presentation US Attorney Hartunian encouraged relators’ counsel to consider filing False Claims Act Qui Tam cases with his office in the Northern District of New York, which includes, the cities of Albany, Syracuse, Binghamton and Plattsburg.  He specifically mentioned being interested in FCA cases involving healthcare, Medicaid, defense contracting and other types of government program fraud.  US Attorney Hartunian emphasized that his office would be interested in cases of all sizes, even ones involving less than one million dollars in losses. He said this is because he is concerned not only with the amount of recoveries but also other important factors, such as patient safety and care and harm to US military personnel.

Qui Tam Case Too Small?

False Claims Act

 

You may be wondering, “Is my Qui Tam Case Too Small to pursue?”  The answer is probably no, not just because of its size.  This does not mean that the amount of potential damages is irrelevant.  Every lawyer will (or should) do a cost-benefit analysis before taking a case, and the Government certainly will do so when its lawyers are making intervention decisions on False Claims Act (FCA) matters.  After all, you cannot rationally spend more money litigating a case than you are likely to recover in damages.  But, generally the most important thing is whether the case’s allegations are meritorious and provable.  Additionally, if you have a whistleblower retaliation component to your case, that might also tip the balance in favor of commencing a lawsuit.

Therefore, while it is true that Relators’ Counsel are often more willing to take an “iffy” case if the upside is quite substantial, you still should be able to find an experienced and capable lawyer to take a small damages case, provided the theory of liability is straightforward and there is strong evidence that can be readily obtained.  Although the $100 million or even billion dollar qui tam FCA cases garner the most media coverage, there are actually many FCA cases that get resolved for somewhere between $100,000 and $1 million.

"Tim McInnis is an amazing attorney. He is intelligent, thorough, ethical, kind and he works very strategically in order to insure the best outcome for his clients. I would trust him with my life. He is not only an excellent attorney, but he is a compassionate person."
Denise A. Romano, January 2004

"Tim McInnis is a superb lawyer for whistleblowers. As both a relator and a lawyer I worked with for more than three and a

On October 14, 2020, medical device maker Merit Medical Systems Inc. (MMSI), of South Jordan, Utah, agreed to pay $18 million to settle allegations the company helped submit false claims to the federal Medicare and TRICARE programs and numerous state Medicaid programs by giving kickbacks to physicians and hospitals to induce the purchase and use of MMSI’s durable medical equipment devices and products. NYC attorney Timothy J. McInnis was a member of the legal team that successfully represented the whistleblower in the case, Charles J. (“CJ”) Wolf, M.D., who was the former Chief Compliance Officer of MMSI.

 

According to Dr. Wolf’s complaint and the government’s settlement agreement, for over six years MMSI paid kickbacks to physicians, medical practices, and hospitals. The payments were made indirectly under the guise of free advertising assistance, practice development, practice support, and so-called “educational” grants. All of this was intended to induce the healthcare providers to purchase and use MMSI’s products, including EmboSphere devices, which are used for uterine fibroid embolization procedures, and QuadraSphere devices, which are used for other types of embolization procedures. Among other things, MMSI used local advertising campaigns to steer patients to healthcare providers as a reward for past sales and to increase future purchases of MMSI products. Dr. Wolf and the government further alleged that MMSI disregarded numerous internal warnings, including from Dr. Wolf, that MMSI’s sales practices potentially violated the healthcare Anti-Kickback Statute (AKS).

 

The lawsuit was filed in the federal court in District of New Jersey, where attorney McInnis formerly served as an Assistant U.S. Attorney. The case is captioned United States ex rel. Wolf v. Merit Medical Systems, Inc., No. 2:16-cv-01855-CCC-MF (D.N.J.). Of the $18 million MMSI is paying to settle the case, $15.21 million will be go to the U.S. Treasury, and the remaining $2.79 million will go to the approximately 30 individual states that also joined the lawsuit.

half years and his counsel and perseverance were always spot on. His work was critical to a successful settlement of the case."
Stephen B. Diamond, Esq., August, 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

Call us anytime 212-292-4573

"Tim McInnis is an amazing attorney. He is intelligent, thorough, ethical, kind and he works very strategically in order to insure the best outcome for his clients. I would trust him with my life. He is not only an excellent attorney, but he is a compassionate person."
Denise A. Romano, January 2004

"Tim McInnis is a superb lawyer for whistleblowers. As both a relator and a lawyer I worked with for more than three and a

On October 14, 2020, medical device maker Merit Medical Systems Inc. (MMSI), of South Jordan, Utah, agreed to pay $18 million to settle allegations the company helped submit false claims to the federal Medicare and TRICARE programs and numerous state Medicaid programs by giving kickbacks to physicians and hospitals to induce the purchase and use of MMSI’s durable medical equipment devices and products. NYC attorney Timothy J. McInnis was a member of the legal team that successfully represented the whistleblower in the case, Charles J. (“CJ”) Wolf, M.D., who was the former Chief Compliance Officer of MMSI.

 

According to Dr. Wolf’s complaint and the government’s settlement agreement, for over six years MMSI paid kickbacks to physicians, medical practices, and hospitals. The payments were made indirectly under the guise of free advertising assistance, practice development, practice support, and so-called “educational” grants. All of this was intended to induce the healthcare providers to purchase and use MMSI’s products, including EmboSphere devices, which are used for uterine fibroid embolization procedures, and QuadraSphere devices, which are used for other types of embolization procedures. Among other things, MMSI used local advertising campaigns to steer patients to healthcare providers as a reward for past sales and to increase future purchases of MMSI products. Dr. Wolf and the government further alleged that MMSI disregarded numerous internal warnings, including from Dr. Wolf, that MMSI’s sales practices potentially violated the healthcare Anti-Kickback Statute (AKS).

 

The lawsuit was filed in the federal court in District of New Jersey, where attorney McInnis formerly served as an Assistant U.S. Attorney. The case is captioned United States ex rel. Wolf v. Merit Medical Systems, Inc., No. 2:16-cv-01855-CCC-MF (D.N.J.). Of the $18 million MMSI is paying to settle the case, $15.21 million will be go to the U.S. Treasury, and the remaining $2.79 million will go to the approximately 30 individual states that also joined the lawsuit.

half years and his counsel and perseverance were always spot on. His work was critical to a successful settlement of the case."
Stephen B. Diamond, Esq., August, 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

"Tim McInnis Law represented my case with the up most professionalism. He communicated with me at every turn of the case ensuring I understood the process as well what was to come next. His patience, comprehension of Qui Tam Law and persistence in getting me the highest amount possible out of the case is unmatched. I wouldn't hesitate to recommend his law firm for a minute."
Don A. Briscoe, September 2016

Call us anytime 212-292-4573

Get FCA Defendants’ Hidden Legal Advice

Ground breaking case opening door to FCA Defendants’ Hidden Legal Advice.  A noteworthy decision was handed down by a federal judge in Georgia on August 29, 2014 concerning a hospital’s waiver of the attorney client privilege.  See Barker v. Columbus Reg’l Healthcare Sys., Case No. 4:12-cv-108 (CDL).  There, the court held that a defendant who does nothing more than say it intends to show at trial that it believed its conduct was “lawful” waived the attorney client privilege for all records and communications relating to that issue.  In other words, according to Barker, a defendant does not have to specifically and expressly assert the “reliance on advice of counsel” affirmative defense to trigger the waiver.  The court reasoned that FCA defendants cannot use a claim of good faith intent as a sword to prevail at trial while simultaneously using the attorney client privilege as a shield to withhold contrary legal advice.

This ruling is a potential game changer for relators attempting to get discovery from FCA defendants, especially on the issue of a defendant’s “knowing” violation of the False Claims Act.  If Barker case is followed widely, it will allow relators to obtain “all of the information at [a defendant’s] disposal when it made the decision to [act as it did],” including all communications to and from all attorneys, not just the selective memos the defendants may want relators and the Government to see.

Whistleblower Immunity

 

Many people ask me, “Can I get Whistleblower Immunity if I file a qui tam False Claims Act case?” This really translates into two related questions: “Can I get into trouble with the authorities and risk paying a fine or going to jail?” And, “Can I still receive a reward for coming forward with my information?” These questions arise because very often (but not always) a whistleblower played some role in carrying out the fraudulent scheme, for example by filling out the false billing forms or invoices that were submitted to the government. In many cases the answer is “yes,” the whistleblower will not be penalized and he or she will still be eligible for a reward. However, no one can say for sure without getting additional facts and consulting the affected governmental authorities. An attorney who is familiar with, and experienced in, criminal prosecutions and immunity matters will know what questions to ask and who to talk to at the government.  That is the only way the attorney can competently guide the client through this complicated issue.

With that caveat in mind, here are some things for a prospective whistleblower who is worried about immunity to consider. Were you the mastermind of the fraudulent scheme or were you just an order follower at a mid- or lower-level within an organization? Did you get any additional compensation from the fraudulent scheme or did you simply receive your regular salary, wages and income? Was there anything unusual about the type of compensation you received (such as cash in a brown paper bag–it does happen) or did you only receive a regular pay check or bank deposit? Did you encourage other people to participate in the fraudulent scheme or did you more or less just go along with others to keep your job?  Did you tell co-workers that what was going on was ok or did you express some misgivings or objections? Were you ever interviewed by a government investigator and, if so, did you lie to that person and/or did you destroy evidence or is what you did wrong limited to assisting on improper business and financial transactions? Knowing the answers to these kinds of questions will most likely enable your attorney to either give you the peace of mind you are seeking or tell you that it is not possible in your particular case.

Qui Tam Whistleblower Lawyers Announce Albany and NYC Alliance

 

Timothy McInnis of McInnis Law (New York, NY) and Thomas Fallati of Tabner Ryan & Keniry (Albany, NY) announced their firms’ formation of a strategic alliance to combine experiences and resources to represent whistleblower clients, including relators in False Claim Act qui tam law suits.  Mr. McInnis is a former federal prosecutor who has been successfully representing whistleblowers since 1999.  Mr. Fallati is also a former federal prosecutor who regularly represents plaintiffs in complex litigation matters.

In making this announcement, Attorney McInnis noted, “Tom and I have known each other for many years and this is the perfect time to jointly handle qui tam cases and other kinds of whistleblower matters, particularly ones arising in the Northern District of New York, which includes Albany, Binghamton, Plattsburgh, Syracuse and Utica.”  Attorney Fallati added, “There is a real need for a robust whistleblower law presence in this region, especially in the areas of healthcare, defense industry and government contracting and grants.”